VistaGen Therapeutics, Inc.(VTGN)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-08-09 | COMMODORE CAPITAL LP 10% Owner | Purchase | +775,756 | +97.06%1,575,000 | $23.15 | $17,961,079 | View SEC filing | |
| 2022-08-22 | GIN JERRY B Director | Purchase | +200,000 | +100.00%200,000 | $0.18 | $35,740 | View SEC filing | |
| 2022-08-19 | Adler Reid G. CHIEF LEGAL OFFICER | Purchase | +300,000 | +866.33%334,629 | $0.17 | $50,910 | View SEC filing | |
| 2022-08-18 | Singh Shawn CHIEF EXECUTIVE OFFICER | Purchase | +600,000 | +2287.11%626,234 | $0.17 | $103,200 | View SEC filing | |
| 2022-07-14 | VHCP Management II, LLC 10% Owner | Sale | -60,000 | -0.29%20,637,286 | $0.89 | $53,400 | View SEC filing | |
| 2021-09-08 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Sale | -30,000 | -29.19%72,786 | $3.13 | $93,750 | View SEC filing | |
| 2021-08-18 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Purchase | +3,750 | +12.14%34,641 | $2.73 | $10,238 | View SEC filing | |
| 2020-08-24 | SAXE JON S Director | Purchase | +30,000 | +150.00%50,000 | $0.69 | $20,700 | View SEC filing | |
| 2019-11-21 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Purchase | +15,000 | +100.00%15,000 | $0.34 | $5,100 | View SEC filing | |
| 2019-03-14 | SAXE JON S Director | Purchase | +20,000 | +100.00%20,000 | $1.26 | $25,288 | View SEC filing | |
| 2017-06-01 | GIN JERRY B Director | Purchase | +150,000 | +200.00%225,000 | N/A | N/A | View SEC filing | |
| 2012-01-09 | Cato Allen Easley 10% Owner | Sale | -1 | -19.93%4.016 | $6149.44 | $6,149 | View SEC filing | |
| 2011-06-03 | JONES STEPHANIE PRESIDENT | Sale | -4,982,103 | -99.64%17,897 | N/A | N/A | View SEC filing |
1-13 of 13